1-(3,4-dimethoxyphenethyl)-4-(2-ethoxyphenyl)piperazine

ID: ALA3902626

Cas Number: 1248-54-0

PubChem CID: 121102

Max Phase: Preclinical

Molecular Formula: C22H30N2O3

Molecular Weight: 370.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1

Standard InChI:  InChI=1S/C22H30N2O3/c1-4-27-20-8-6-5-7-19(20)24-15-13-23(14-16-24)12-11-18-9-10-21(25-2)22(17-18)26-3/h5-10,17H,4,11-16H2,1-3H3

Standard InChI Key:  NSQCHSZFXOYJID-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   22.5606   -7.6629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2775   -8.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9786   -7.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9669   -6.8266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2541   -6.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5530   -6.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6721   -6.4085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3849   -6.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0860   -6.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0743   -5.5723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3615   -5.1733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6604   -5.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3925   -7.6246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1052   -8.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8595   -8.0810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1467   -7.6820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0276   -8.1151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0393   -8.9322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7521   -9.3353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4573   -8.9172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4456   -8.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7328   -7.7011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8075   -7.6056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3372   -9.3454    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3467  -10.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3186   -7.7128    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6153   -8.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 13 14  1  0
  8 13  1  0
  4  7  1  0
 15 16  1  0
 17 18  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 22  2  0
 18 19  2  0
 16 21  1  0
  1 15  1  0
 14 23  1  0
 24 25  1  0
 18 24  1  0
 26 27  1  0
 17 26  1  0
M  END

Associated Targets(Human)

ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.49Molecular Weight (Monoisotopic): 370.2256AlogP: 3.47#Rotatable Bonds: 8
Polar Surface Area: 34.17Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.67CX LogP: 3.83CX LogD: 3.37
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.04

References

1. Silva RO, de Oliveira AS, Nunes Lemes LF, de Camargo Nascente L, Coelho do Nascimento Nogueira P, Silveira ER, Brand GD, Vistoli G, Cilia A, Poggesi E, Buccioni M, Marucci G, Bolognesi ML, Romeiro LAS..  (2016)  Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor.,  122  [PMID:27448917] [10.1016/j.ejmech.2016.06.052]

Source